Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SC vs Oral Furosemide in Heart Failure
NCT02350725Phase 2Completed
- Sponsor
- scPharmaceuticals Inc.
- Start
- Dec 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of furosemide in heart failure (HF) (2 arms), sponsored by scPharmaceuticals Inc. Primary endpoint: Diuresis and natriuresis at 8 hours. Started Dec 2014; status: completed.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02350725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02350725.